Drugs / Japanese Encephalitis Inactivated Mouse Brain Vaccine
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 2 | NCT00441259 Comparator | Jan 2007 → Feb 2011 | Japanese encephalitis | Sanofi | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Japanese Encephalitis Inactivated Mouse Brain Vaccine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00441259 ↗ |
| Known as | JE-MBDV | “Subjects will be enrolled by age group and randomised to either ChimeriVax™-JE (JE-CV) or JE Mouse Brain Derived Vaccine (JE-MBDV).” NCT00441259 ↗ |
| Modality | Vaccine | “mouse brain-derived vaccine (MBDV)” NCT00441259 ↗ |